ࡱ>    U" bjbjnn.`aa/$ eeeeeyyyyDy^KeJgJgJgJgJgJgJ$LOTJe2 2 2 JeeK3332 4eeeJ32 eJ33{B|C<f BQJ.K0^K CP/P$CCPeEL63,JJJ&2^K2 2 2 2 P m +:"#"&/ 4;O ?@>2545==O 70:C?V2;V G5@57 A8AB5<C 5;5:B@>==8E 70:C?V25;L 0:C?V2;O 74VA=NTBLAO :5@CNG8AL >AB0=>2>N 01V=5BC V=VAB@V2 #:@0W=8 2V4 28.02.2022 @. ! 169 5O:V ?8B0==O 74V9A=5==O >1>@>==8E B0 ?C1;VG=8E 70:C?V25;L B>20@V2, @>1VB V ?>A;C3 2 C<>20E 2>T==>3> AB0=C 7V 7<V=0<8. 0<>2=8:: 1.1.09<5=C20==O: ><C=0;L=5 =5:><5@FV9=5 ?V4?@8T<AB2> 8W2AL:0 <VAL:0 :;V=VG=0 ;V:0@=O !12 28:>=02G>3> >@30=C 8W2AL:>W <VAL:>W @048 (8W2AL:>W <VAL:>W 45@602=>W 04<V=VAB@0FVW). 1.2. >4 70  #: 25680639 1.3. VAF57=0E>465==O: 01103 <. 8W2, 2C;. V428A>FL:>3>, 4- 2. >7<V@ 1N465B=>3> ?@87=0G5==O 70 :>HB>@8A>< 01> >GV:C20=0 20@BVABL 70:C?V2;V B>20@C : 1600 300,00 (48= <V;L9>= HVABA>B B8AOG B@8AB0 3@=. 00 :>?) 7 . 3.=D>@<0FVO ?@> ?@54<5B 70:C?V2;V: 3.1. 09<5=C20==O ?@54<5BC 70:C?V2;V B0 :>4 2V4?>2V4=> 4> 548=>3> 70:C?V25;L=>3> A;>2=8:0 CPV  $0@<0F52B8G=0 ?@>4C:FVO - 33600000-6 3.2. 09<5=C20==O, :V;L:VABL, B5E=VG=V B0 O:VA=V 28<>38 4> ?@54<5BC 70:C?V2;V: !, ??V6=0@>4=0 =5?0B5=B>20=0 =072009<5=C20==O (01> 5:2V20;5=B)4. 28<V@CV;L:VABL>B !1 Sodium chloride, Glucose, Bupivacaine, Mannitol, Electrolytes in combination with other drugs, Levofloxacin and ornidazole, Decamethoxine, Ciprofloxacin, Saccharated iron oxide1Sodium chloride" . % - @>7G8= 4;O V=DC7V9, 9 <3/<;, ?> 100 <;D;20002Sodium chloride" . % - @>7G8= 4;O V=DC7V9, 9 <3/<;, ?> 250 <;D;25003Sodium chloride" . % - @>7G8= 4;O V=DC7V9, 9 <3/<;, ?> 500 <;D;30004Glucose. @>7G8= 4;O V=DC7V9, 100 <3/<; ?> 200 <;D;3005Glucose. @>7G8= 4;O V=DC7V9, 50 <3/<; ?> 200 <;D;6006Glucose. @>7G8= 4;O V=DC7V9, 50 <3/<; ?> 400 <;D;3007Bupivacaine >7G8= 4;O V='T:FV9, 5,0 <3/<; ?> 5 <;.0<?8008Bupivacaine >7G8= 4;O V='T:FV9, 2,5 <3/<; ?> 200 <;.$;3009Mannitol@>7G8= 4;O V=DC7V9 150 <3/<;, ?> 200 <;.D;24010Electrolytes in combination with other drugs ! " 01> 0=0;>3, @>7G8= 4;O V=DC7V9 ?> 200 <; C ?;OH:0ED;36011Levofloxacin and ornidazole@>7G8= 4;O V=DC7V9, 5 <3/2,5 <3/<; ?> 200 <; D;12012Decamethoxine@>7G8= 4;O 7>2=VH=L>3> 70AB>AC20==O, 0,2 <3/<;, ?> 200 <;.D;30013Decamethoxine@>7G8= 4;O 7>2=VH=L>3> 70AB>AC20==O, 0,2 <3/<;, ?> 400 <;.D;40014Ciprofloxacin@>7G8= 4;O V=DC7V9, 2 <3/<;, ?> 100 <;.D;10015Saccharated iron oxide@>7G8= 4;O 2=CB@VH=L>25==8E V='T:FV9 20 <3/<; ?> 5 <; 0<?50GV:C20=0 20@BVABL ;>BC 495500,00 3@=.>B ! 2 Sevoflurane1Sevoflurane@V48=0 4;O V=30;OFV9 100 % ?> 250 <;, 7 :>;?0G:. A8AB. quik filD;80GV:C20=0 20@BVABL ;>BC 226000,00 3@=.>B ! 3 Atracurium1Atracurium@>7G8= 4;O V='T:FV9, 10 <3/<;, ?> 5 <;D;1250GV:C20=0 20@BVABL ;>BC 74800,00 3@=.>B ! 4 Metoprolol1 Metoprolol@>7G8= 4;O V='T:FV9 1 <3/<; ?> 5 <;.D;50GV:C20=0 20@BVABL ;>BC 27 000,00 3@=.>B ! 5 Ipidacrin, Ademetionine, Pantoprazole, Quetiapine1Ipidacrin >7G8= 4/V=.15<3/<; 1<;0<?2002Ademetionine V>DV;V70B 4/@-=C 4/V=L5:F.400<3 D;+ 1 0<? @>7G8==8:0 0<?753Pantoprazole>@>H>: 4;O @>7G8=C 4;O V=`T:FV9, 40 <3 D;8004Quetiapine"01;5B:8, 2:@8BV ?;V2:>2>N >1>;>=:>N, ?> 25 <3B01300GV:C20=0 20@BVABL ;>BC 72000,00 3@=.>B ! 6 ketorolac tromethamine, pitofenone hydrochloride, fenpiverinium bromide, Pentoxifylline, Drotaverine, Metamizole sodium, Thiopental, Barium sulfate without suspending agents, Diclofenac, Potassium chloride, Aciclovir, Multienzymes (lipase, protease etc.), Fluconazole, Fluconazole, Ibuprofen, Comb drug, Diphenhydramine, Etamsylate, Cefoperazone and beta-lactamase inhibitor, Papaverine1ketorolac tromethamine, pitofenone hydrochloride, fenpiverinium bromide.@>7G8= 4/V=. ?> 2 <; 0<?4002Pentoxifylline@>7G8= 4/V=. 20 <3/<; ?> 5 <;0<?5003Drotaverine@>7G8= 4;O V='T:FV9, 20 <3/<; ?> 2 <; 0<?20004Metamizole sodium @>7G8= 4;O V=`T:FV9, 500 <3/<;, ?> 2 <;0<?60005Thiopental;V>DV;V70B 4;O @>7G8=C 4;O V='T:FV9 ?> 1,0D;2406Barium sulfate without suspending agents?>@>H>: 4;O ?@83>BC20==O ACA?5=7VW ?> 80 3D;1607Diclofenac@>7G8= 4;O V= T:FV9, 25 <3/<; ?> 3 <; 0<?20008Potassium chloride@>7G8= 4/V=D. 4 %,100 <; D;2409Aciclovir?>@>H>: 4;O @>7G8=C 4;O V='T:FV9 ?> 250 <3D;5010Multienzymes (lipase, protease etc.)B01;5B:8 30AB@>@578AB5=B=VB01500011FluconazoleB01;5B:8, 2:@8BV >1>;>=:>N, ?> 50 <3 B0150012FluconazoleB01;5B:8, 2:@8BV >1>;>=:>N, ?> 100 <3B0150013Ibuprofen@>7G8= 4;O V=DC7V9, 4 <3/<; ?> 100 <; C :>=B59=5@V C?13514Comb drug(!, 01> 0=0;>3) @>7G8= ?> 50 3 C D;0:>=0ED;6015Diphenhydramine@>7G8= 4;O V='T:FV9, 10 <3/<;; ?> 1 <; 0<?500016Etamsylate@>7G8= 4;O V='T:FV9 12,5 % ?> 2 <;0<?300017Cefoperazone and beta-lactamase inhibitor ?>@>H>: 4;O @>7G8=C 4;O V='T:FV9 ?> 1000 <3/1000 <3 ?> 1 D;0:>=C 7 ?>@>H:><C?20018Papaverine@>7G8= 4;O V='T:FV9, 20 <3/<; ?> 2 <; 0<?3000GV:C20=0 20@BVABL ;>BC 183500,00 3@=.T V X h j l n    @ B D F H J \ Һҳxlc\xXTh "zh+ h9h9h95CJaJh9h95CJaJ hzLbh9 hRn>hRn>h9hzLbCJaJh hRn>CJaJhRn>hRn>CJaJ hzLbhRn>hRn> hYrhYr hzLbhzLb hzLbhzhzLbmHnHsH hzLbh !h !5 h !5hwhw5hghJ[5CJhghF.5CJV X l  84p $$Ifa$gdj1$a$gdQn$a$gdx#\^gdgd9^gdzLb & Fgdzgd !$a$gdw$a$gdF.\ b d f 02"0268LPRpʽ~y~rg_g[hhjB*phhNhB*ph hx#\h u hYr5hA)h u5hNh5h uhphp5hp h2hhNhmHnHsH hj hNhhyPhmHnHsH hzLbh8$h8$ h9h9h+h+h+5 hX i5 h "z5 hW35 hkB 5hGz  , $$Ifa$gd#kd$$Ifl,r* X#&&&&& t0644 lap2ytj1  8hjlj FL b(8 (,|hƭ h#hdqh#hdq5\h h \ h h h#h h#h# h#hh#h#5\h#h5\h#h )5\ h#h )= 2 $$Ifa$gdj1skd$$Ifl,X#&# t0644 lap ytj1, $$Ifa$gdj1kd$$Iflr* X#&&&& t0644 lap2ytj1@FP $$Ifa$gdj1PRVv, $$Ifa$gdj1kdy$$Iflr* X#&&&& t0644 lap2ytj1v $$Ifa$gdj1, $$Ifa$gdj1kdp$$Ifl1r* X#&&&& t0644 lap2ytj1hnv $$Ifa$gdj1vx|, $$Ifa$gdj1kdg$$Ifl r* X#&&&& t0644 lap2ytj1 $$Ifa$gdj1, $$Ifa$gdj1kd^$$Ifl r* X#&&&& t0644 lap2ytj1lrz $$Ifa$gdj1z|, $$Ifa$gdj1kdU$$Ifl r* X#&&&& t0644 lap2ytj1 $$Ifa$gdj1, $$Ifa$gdj1kdL$$Ifl'r* X#&&&& t0644 lap2ytj1jpx $$Ifa$gdj1xz~, $$Ifa$gdj1kdC$$Iflr* X#&&&& t0644 lap2ytj1 $$Ifa$gdj1R, $$Ifa$gdj1kd@ $$Iflr* X#&&&& t0644 lap2ytj1R $$Ifa$gdj1 , $$Ifa$gdj1kd7 $$Iflr* X#&&&& t0644 lap2ytj1 | $$Ifa$gdj1, $$Ifa$gdj1kd. $$Ifl r* X#&&& t0644 lap2ytj1$*2 $$Ifa$gdj124:V, $$Ifa$gdj1kd% $$Ifl=r* X#&&&& t0644 lap2ytj1V $$Ifa$gdj1, $$Ifa$gdj1kd $$Ifl)r* X#&&&& t0644 lap2ytj1NT\ $$Ifa$gdj1\^d, $$Ifa$gdj1kd$$Ifl#r* X#&&&& t0644 lap2ytj1 $$Ifa$gdj1`, $$Ifa$gdj1kd $$Ifl r* X#&&&& t0644 lap2ytj1`b $$Ifa$gdj1skd$$IflX#&# t0644 lap ytj1*06 $$Ifa$gdj1skd$$Ifl,X#&# t0644 lap ytj168, $$Ifa$gdj1kd#$$Iflr* X#&&&& t0644 lap2ytj1 $$Ifa$gdj1skd$$IflX#&# t0644 lap ytj1 * $$Ifa$gdj1skd$$Ifl,X#&# t0644 lap ytj1*,z, $$Ifa$gdj1kd<$$Iflr* X#&&&& t0644 lap2ytj1z| $$Ifa$gdj1skd3$$IflX#&# t0644 lap ytj1  $$Ifa$gdj1skd$$Ifl,X#&# t0644 lap ytj1f, $$Ifa$gdj1kdU$$Ifl,r* X#&&&&& t0644 lap2ytj1fh $$Ifa$gdj1skdF$$Ifl,X#&# t0644 lap ytj1(08 $$Ifa$gdj1skd$$Ifl,X#&# t0644 lap ytj1 &(.46` ^, $$Ifa$gdj1kdh$$Ifl,r* X#&&&& t0644 lap2ytj1^ $$Ifa$gdj1 , $$Ifa$gdj1kd_$$Iflr* X#&&& t0644 lap2ytj1 R X ` $$Ifa$gdj1` b f | , $$Ifa$gdj1kdV$$IflOr* X#&&&& t0644 lap2ytj1| $$Ifa$gdj1 :!, $$Ifa$gdj1kdM$$Iflr* X#&&&& t0644 lap2ytj1:!$B$`$, $$Ifa$gdj1kdf$$Iflr* X#&&& t0644 lap2ytj1`$$$$ $$Ifa$gdj1$$$$, $$Ifa$gdj1kd]$$IflFr* X#&&& t0644 lap2ytj1$% %*% $$Ifa$gdj1*%,%0%V%, $$Ifa$gdj1kdT$$Iflr* X#&&& t0644 lap2ytj1V%%%% $$Ifa$gdj1%%%%, $$Ifa$gdj1kdK$$Ifl3r* X#&&& t0644 lap2ytj1%*&0&8& $$Ifa$gd_Z $$Ifa$gdj18&:&>&&, $$Ifa$gdj1kdB $$Iflr* X#&&&& t0644 lap2ytj1&&&& $$Ifa$gdj1&&&', $$Ifa$gdj1kd9!$$Iflr* X#&&&& t0644 lap2ytj1'^'f'p' $$Ifa$gdj1p'r'v'', $$Ifa$gdj1kd0"$$Iflar* X#&&&& t0644 lap2ytj1'''' $$Ifa$gdj1'''', $$Ifa$gdj1kd'#$$IflXr* X#&&&& t0644 lap2ytj1'N(T(Z( $$Ifa$gdj1Z(\(b((, $$Ifa$gdj1kd$$$Iflqr* X#&&&& t0644 lap2ytj1(((( $$Ifa$gdj1((`)f)l)n)))))****+++++++,, ,~------&h~TXnrHL^bvx<BHJ& h#hF h#h{7h#h{75\h#hc5\U h#h# h#h3G h#h ) h#hcK(((), $$Ifa$gdj1kd%$$Iflr* X#&&& t0644 lap2ytj1)`)h)p) $$Ifa$gdj1p)r)x)), $$Ifa$gdj1kd &$$IflTr* X#&&&& t0644 lap2ytj)))) $$Ifa$gdj1)))*, $$Ifa$gdj1kd'$$Iflr* X#&&&& t0644 lap2ytj*p*v*~* $$Ifa$gdj1~****, $$Ifa$gdj1kd'$$Iflr* X#&&&& t0644 lap2ytj1*++ + $$Ifa$gdj1 +++4+, $$Ifa$gdj1kd($$Ifl;r* X#&&&& t0644 lap2ytj14++++ $$Ifa$gdj1++++, $$Ifa$gdj1kd)$$Ifl_r* X#&&&& t0644 lap2ytj1++, , $$Ifa$gdj1 ,,,l,, $$Ifa$gdj1kd*$$Iflr* X#&&&& t0644 lap2ytj1l,- -- $$Ifa$gdj1---0-, $$Ifa$gdj1kd+$$Ifl r* X#&&& t0644 lap2ytj10-~--- $$Ifa$gdj1---, $$Ifa$gdj1kd,$$IflEr* X#&&&& t0644 lap2ytj1--v $$Ifa$gdj1skd-$$IflX#&# t0644 lap ytj1>B ! 7 Magnesium (different salts in combination), naphazoline, Theophylline, Omeprazole, Glucose, Ketorolac, Dexketoprofen, Nalbuphine, Dexamethasone and antiinfectives, Clopidogrel, Iohexol, Torasemid, Nifedipine, Insulin (human Vitamin B1 in combination with vitamin B6 and/or vitamin B12, Comb drug, Meloxicam1Magnesium (different salts in combination)(!  01> 0=0;>3) @>7G8= 4;O V= T:FV9, ?> 10 <; 0<?5002naphazoline0,1% -10 <; :@.2 =VA ?>;V5B8; D;.D;203Theophylline@>7G8= 4;O V=`T:FV9, 20 <3/<; ?> 5 <;0<?12004Omeprazole;V>DV;V70B 4;O @>7G8=C 4;O V='T:FV9 ?> 40 <3 C D;0:>=0E ! 1D;34005Omeprazole :0?AC;8 ?> 20 <3 :0?A90006Glucose@>7G8= 4;O V='T:FV9 40 % ?> 10 <; 0<?5007Ketorolac@>7G8= 4;O V='T:FV9, 30 <3/<;, ?> 1 <; 2 0<?C;V 0<?124508Dexketoprofen@>7G8= 4;O V='T:FV9, 50 <3/2 <; ?> 2 <; 0<?25009Nalbuphine@>7G8= 4;O V='T:FV9 10 <3/<; ?> 1 <; 0<?50010Dexamethasone and antiinfectives:@0?;V C 2CE> 7,5 <; C?2011ClopidogrelB01;5B:8, 2:@8BV ?;V2:>2>N >1>;>=:>N, ?> 75 <3 B0130012Iohexol@>7G8= 4;O V='T:FV9, 350 <3 9>4C/<; ?> 50 <; D;3013Iohexol@>7G8= 4;O V='T:FV9, 350 <3 9>4C/<; ?>100 <; D;5014Torasemid@>7G8= 4;O V='T:FV9 20 <3/4 <; ?> 4 <;0<?20015Nifedipine:@0?;V >@0;L=V 2 % ?> 25 <; C D;0:>=VD;516Insulin (human@>7G8= 4;O V='T:FV9, 100 /<;, ?> 5 <; D;1017Vitamin B1 in combination with vitamin B6 and/or vitamin B12@>7G8= 4;O V='T:FV9 ?> 2 <;0<?22518Comb drug(, 01> 0=0;>3) <07L ?> 40 3 C BC1VC?4019Meloxicam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vx|<DL $$Ifa$gdj1skdU.$$Ifl,X#&# t0644 lap ytj1LNRj, $$Ifa$gdj1kd.$$Iflr* X#&&&& t0644 lap2ytj1j $$Ifa$gdj1, $$Ifa$gdj1kd/$$Ifl,r* X#&&&& t0644 lap2ytj1&.8 $$Ifa$gdj1&,46&(, *,"$&~.46<>@268<>Z"&x4hjprx\bd򽶽hj h#h# h#hF h#hET h#h "z h Ih5 h IhNq h Ih )h I h#h3G h#h ) h#h5F8:>T, $$Ifa$gdj1kd0$$Ifl,r* X#&&&&& t0644 lap2ytj1T $$Ifa$gdj1, $$Ifa$gdj1kd1$$Iflr* X#&&&& t0644 lap2ytj1(2 $$Ifa$gdj1248H, $$Ifa$gdj1kd2$$Ifl,r* X#&&&& t0644 lap2ytj1H $$Ifa$gdj1, $$Ifa$gdj1kd3$$Iflr* X#&&&& t0644 lap2ytj". $$Ifa$gdj1 $$Ifa$gdxg.04P, $$Ifa$gdj1kd4$$Ifl r* X#&&&& t0644 lap2ytj1P $$Ifa$gdj1, $$Ifa$gdj1kd5$$Iflr* X#&&&& t0644 lap2ytj$, $$Ifa$gdj1,.4v, $$Ifa$gdj1kd6$$Ifl r* X#&&&& t0644 lap2ytjv $$Ifa$gdj1, $$Ifa$gdj1kd7$$Iflr* X#&&& t0644 lap2ytj1.6> $$Ifa$gdj1>@FV, $$Ifa$gdj1kd8$$IflFr* X#&&&& t0644 lap2ytj1V $$Ifa$gdj1 $$Ifa$gd I, $$Ifa$gdj1kd}9$$Ifl r* X#&&&& t0644 lap2ytj128> $$Ifa$gdj1>@FZ, $$Ifa$gdj1kdt:$$Ifl r* X#&&&& t0644 lap2ytj1Z $$Ifa$gdj1, $$Ifa$gdj1kdk;$$Iflr* X#&&&& t0644 lap2ytj"(, $$Ifa$gdj1,.4R, $$Ifa$gdj1kdb<$$Ifl r* X#&&&& t0644 lap2ytj1R $$Ifa$gdj12, $$Ifa$gdj1kdY=$$Ifl r* X#&&&& t0644 lap2ytj12jrz $$Ifa$gdj1z|, $$Ifa$gdj1kdP>$$Ifl r* X#&&& t0644 lap2ytj1 $$Ifa$gdj1, $$Ifa$gdj1kdG?$$Ifl,r* X#&&&& t0644 lap2ytj1\dl $$Ifa$gdj1djnV :<>J\^`ûда۩Ԛԍtitd hn#5hAr5mHnHsHhjCJmH"nHuhjhjCJmH"nHuhNhmHnHsHhNh5 hNhGz hGzhGzhg hh'hh<mHsHh|{hmHnHsHh hNhh<hhm h )h "zh "z h#h ) h#h "z'ln, $$Ifa$gdj1kd>@$$Ifl+r* X#&&&& t0644 lap2ytjV`xfxxxxxxx$1$7$8$H$^a$gdGz$a$gdGz $`a$gdmskd5A$$IflX#&# t0644 lap ytj1 ` fhjl 68<>FHZ\ ¾}tkhjmH"nHuhmH"nHuhwmH"nHuhQnhQnmH"nHuhjmH"nHuhthjmHnHsHuhjmHnHsHuhmHnHsH hwhg hXhXhXh h|{h hNh ! hw5 hGz5hGzh !hx hNhl>fH $a$gdQn$[$\$a$gdGz$a$gdGz,1h. A!"R#n$n% $$If!vh#v#v#v#v#v:V l, t06555559p2ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l1 t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l' t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t06,5555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l= t065555599p2ytj1$$If!vh#v#v#v#v#v:V l) t065555599p2ytj1$$If!vh#v#v#v#v#v:V l# t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#:V l t065#9p ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#:V l t065#9p ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#:V l t065#9p ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l, t06555559p2ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l, t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V lO t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V lF t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l3 t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V la t065555599p2ytj1$$If!vh#v#v#v#v#v:V lX t065555599p2ytj1$$If!vh#v#v#v#v#v:V lq t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V lT t065555599p2ytj$$If!vh#v#v#v#v#v:V l t065555599p2ytj$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l; t065555599p2ytj1$$If!vh#v#v#v#v#v:V l_ t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V lE t065555599p2ytj1$$If!vh#v#:V l t065#9p ytj1$$If!vh#v#:V l, t065#9p ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l, t065555599p2ytj1$$If!vh#v#v#v#v#v:V l, t06555559p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V l, t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj$$If!vh#v#v#v#v#v:V l  t065555599p2ytj$$If!vh#v#v#v#v#v:V l t065555599p2ytj1$$If!vh#v#v#v#v#v:V lF t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l t065555599p2ytj$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l  t065555599p2ytj1$$If!vh#v#v#v#v#v:V l, t065555599p2ytj1$$If!vh#v#v#v#v#v:V l+ t065555599p2ytj$$If!vh#v#:V l t065#9p ytj1s2&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@_HmH"nH"sH"tH"J`JJ[1KG=K9CJ_HaJmHnHsH"tHu@@@ J[ 03>;>2>: 1$@&CJuFF J[ 03>;>2>: 2$$@&a$CJ uBA B A=>2=>9 H@8DB 0170F0Xi@X 1KG=0O B01;8F04 l4a .k . 5B A?8A:0 FBF J[A=>2=>9 B5:AB$a$CJuLL Rn> =0:1#CJOJQJ^JaJmH sH tH u^^ k` =0: =0: =0:#CJOJQJ^JaJmH sH tH u,!,  ng-bindingp/1p1KG=K9 (251) =0:, =0:2 =0:CJaJmHnHsH"tH"uV^@BV1KG=K9 (251), =0:2dd[$\$tH"RORR  170F A?8A:011$7$8$H$^m$uBaB iapple-converted-space`Yr`}!E5<0 4>:C<5=B0-D M CJOJQJ^JaJJJN0~ "5:AB 2K=>A:8CJOJQJ^JaJ`/`N0~"5:AB 2K=>A:8 =0:#CJOJQJ^JaJmHnHsH"upp ) !5B:0 B01;8FK7:V0PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V{+N8aq-*GlLi˽6Lj3~pmGo 1*?f8&,ɴ8N>hR*Պ"(zsy2!#YQ$\h2軧>:HC A84Bq.UJR_O]-4k!ᣄD=zvg?s6re؝GT{<˷/|N:OWB_?>xo'hGIs ;WY ;ɛY CDtv<(Fr Ȃ`3Ax&sA,/fvXb9<'O:*B{Yg2A E@Sc.Ɩ Ĉ6%pn5$CcT< / AȷNQ۪xD½S#\r""`t\ SƘs֫%Ȍ=tD]ϋ1eA ; qc?Pȹ„ ;D~ /$`\ (&d` Ea PvvzxR 2V\`6*zf8^ ` | :!)#<$`$$$*%V%%%8&&&'p''''Z((()p)))*~** +4+++ ,l,-0---vLj8T2H.P,v>V>Z,R2zl  !"#$%&'()*+,-./0123456789:;<=>?@ABCDFGHIJKLMNOPQRSTUVWXYZ[\]^_`bcdefghijklmnopqrs8@0(  B S  ?K K K K K "R%1$)V-1$C*urn:schemas-microsoft-com:office:smarttagsmetricconverter 01103 <01103, <40 350 380 3 ProductID r(#.#@#C#1$ ST*,56 HL 78BCLNNOQRVXij3467:<EFtuwx{}  4578;=GHpqstwy{|=>@ADFHIVW& ' ) * - / 1 2 H I        C E W Y e f     2 4 m o z { ( ) + , / 1 = > l m p q t v (*tu   GHKLPR^_#$'(,.BC\]_`cepq$%(),.01<=bcfgjlnoxy67:;?ACDNOqruvz|~  3478<>eg  =>@ACESTyz}~  -.1257BCstwx}!"78:;=?ABMN}~  :;>?BDFGQRwxz{}~ #%'(12]^`aceghqrQWZ`MOWbfg` a !!!! #R###.$1$ ,66NOj4Fu 5Hq|>W' I  f  4 o { ) > m  H_$q%=cy7Or 4g>Tz .CtN~;Rx2^rR###.$1$U  ..ll77ss~DD=HIJee`ciO#O##.$1$Ix_%'O&p&'29pIUv$l4:6UMu[^`CJo(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`CJo(hH.h ^`hH.h L^`LhH.h   ^ `hH.h \ \ ^\ `hH.h ,L,^,`LhH.h ^`hH.h ^`hH.h L^`LhH.h^`CJo(hH.h ^`hH.h L^`LhH.h   ^ `hH.h \ \ ^\ `hH.h ,L,^,`LhH.h ^`hH.h ^`hH.h L^`LhH.h^`CJo(hH.h ^`hH.h L^`LhH.h   ^ `hH.h \ \ ^\ `hH.h ,L,^,`LhH.h ^`hH.h ^`hH.h L^`LhH.h^`CJo(hH.h ^`hH.h L^`LhH.h   ^ `hH.h \ \ ^\ `hH.h ,L,^,`LhH.h ^`hH.h ^`hH.h L^`LhH.^`.^`.pp^p`.@ @ ^@ `.^`.^`.^`.^`.PP^P`.pIIx_%&'2v$l'O&6UMudbdbdbdbdbb >`I+  q>y^X $*l $=%{%)J'(8e8*c,-58JBBNC-.I2LO!Tk?niuoo yQ306  m 31 I bq <L* [*c Kh 0x`NccAVW3#5q_K[ 0 kB 4V !X" #n#"$"$8$%h %l%eJ&J& ):h):*`j*eG+ "-0.F."0:1S25g?5G61E7ls;49=l>Rn>d@xB!CnCMDCrD9E E`1E*F''G3G;G@GNfHTcIuJKKQ,NOyP=RuR?S5SETKMTyV_VUWXhX-pZx#\Lj\];\]^E2_JP`k`Rr`zLbdPgxgn|hX iVi j@SjrpHGS >1Gd u"YzP"QnGG_=@[^r{7XClKmXjfJ.]<_1@J2?GWmp I'xL$pq8c#g*)UZfgNq /]:w9$OHi39 A+A)/$1$@ X# uuug/$ D@$*,UnknownG.[x Times New Roman5Symbol3. .[x Arial7. [ @Verdana5. .[`)Tahoma9. . Segoe UIA$BCambria Math"qhHGkB'kB' #  # !nr4$$ 3qHP ?J[2!xx ]   0B25@46CN Useradmin$      Oh+'0  8 D P \hpxUserNormaladmin6Microsoft Office Word@@@Ey@ #  ՜.+,0 hp  Home$     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~  Root Entry F1<Data A1Table,PWordDocument.`SummaryInformation(DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 MSWordDocWord.Document.89q